Most advances in the diagnosis, treatment, and care of patients with melanoma and skin cancer have occurred because of oncology clinical trials.
Thanks to discoveries in clinical trials for skin cancer and melanoma, “We have two new ways of approaching melanoma: directly attacking the melanoma cells with new molecular therapies, and immune therapies,” he says. “My passion has been to help develop these medical treatments for melanoma. The progress is tremendous. We now have patients with widespread melanoma who traditionally would have had about six months to live. Now almost half of these patients are being cured or have long-term survival.”